CLINICAL TRIAL
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Intrapartum polymerase chain reaction for detection of group B streptococcus colonisation.

AIMS: Lower vaginal swabs were collected to compare the intrapartum polymerase chain reaction (PCR) test to the standard antepartum culture for detection of group B streptococcus (GBS) colonisation.

MATERIALS AND METHODS: Four hundred and forty-five pregnant women with documented antepartum GBS cultures, who did not receive either antepartum or intrapartum antibiotics, were included in this prospective study. At the time of delivery and before the intrapartum antibiotic prophylaxis (IAP), double swabs were collected, one of the swab was used in the GBS molecular-based (PCR) test and the other was processed for GBS culture in Ahmadi Hospital Clinical Laboratory. Neonates were examined after delivery to diagnose GBS sepsis, and using intrapartum GBS culture as gold standard test; the intrapartum PCR test was compared to the antepartum culture.

RESULTS: The sensitivity and specificity of antepartum culture to diagnose GBS colonisation were 73 & 95.5%, respectively, compared with 98.3% sensitivity & 99% specificity for intrapartum PCR test (P > 0.05). Although the intrapartum PCR test was more accurate (98.8%) for detection of GBS colonisation than antepartum culture (90%), its accuracy was significantly different. The neonatal GBS sepsis was significantly related to positive intrapartum cultures, and intrapartum PCR tests, but was not related to positive antepartum cultures (the IAP to the antepartum GBS-positive mothers reduces GBS sepsis of their neonates).

DISCUSSION: The intrapartum PCR test is an accurate bedside test and it has the potential to be used as intrapartum screening for GBS colonisation allowing appropriate management of mothers and neonates.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app